Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size
人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响
基本信息
- 批准号:9789908
- 负责人:
- 金额:$ 21.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-21 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAffectAntibodiesAntibody ResponseAntiviral AgentsBacteriaBreast FeedingBreastfed infantCellsClinicalColostrumComplexConflict (Psychology)CountryDataElementsExhibitsExposure toFc ReceptorHIVHIV InfectionsHIV vaccineHealth StatusHighly Active Antiretroviral TherapyHumanHuman MilkImmune responseInfantInfectionIngestionInnate Immune SystemKnowledgeLaboratoriesLactationLeukocytesLymphocyteMaternal antibodyMediatingMilkMother-to-child HIV transmissionMothersParasitesPhagocytesPhagocytosisPostpartum PeriodPreventionPropertyPublishingResourcesRiskRoleSamplingSatellite VirusesSecretory Immunoglobulin ASiteTimeToxic effectVaccinesVariantVertical Disease TransmissionVirionVirusVirus DiseasesWomanYeastsantibody-dependent cell cytotoxicitydiscrete dataexperimental studygranulocyteindividual variationinfant deathlactation periodmonocytepathogenpreferencepreventprotective effectresponsetransmission processvaccine trial
项目摘要
Project Summary
Mother-to-child transmission (MTCT) of HIV remains a crisis in resource-limited countries where HIV is
prevalent. Approximately 200,000 MTCTs of HIV occur annually, with as many as half of infections being due
to exposure via breastmilk (BM) [1, 2]. Yet, only ~10-15% of infants breastfed by HIV-infected mothers actually
become infected, suggesting a strong protective effect of BM itself [1-5]. Though multiple studies have
demonstrated the protective effect of human BM against HIV MTCT [1-10], the contribution of the milk’s cellular
component has been relatively overlooked, despite evidence that maternal leukocytes are functional beyond
the sites of ingestion [11-15]. The only clinical HIV vaccine trial to show efficacy, RV144, and many other
studies have correlated activities mediated by the constant (Fc) Ab domain with protection from HIV acquisition
and this is documented similarly with other pathogens [16-29]. Though demonstrated as necessary for the
clearance of numerous viral infections, one essential Fc-mediated response--Ab-dependent cellular
phagocytosis (ADCP)--has been relatively understudied in the context of HIV, particularly in the case of
prevention of MTCT [30-37]. Colostral phagocytes can perform ADCP of bacteria, parasites and yeast
opsonized with maternal Abs; however, this has not been studied with regard to HIV or HIV-infected cells [38-
44]. Furthermore, the potential contribution of ADCP to protection from MTCT of HIV has not been studied with
regard to impact of phagocytic target size (e.g., cell-free and cell-associated virus), or the effects of the
dynamic leukocyte composition of BM over the lactation period [45-50]. Only conflicting and/or small studies
have been conducted regarding the relevance of Ab subclass in Fc-mediated activity, especially in BM [16, 42,
51-57]. Given the substantial gap in present knowledge of the potential contribution of ADCP activity by BM
phagocytes to prevention of MTCT of HIV, it is critical to develop a multidimensional, comprehensive
understanding of ADCP by the relevant primary cells in BM. The proposed study aims to fill this knowledge
gap. AIM 1 will address the impact of phagocytic target size/type on ADCP by BM cells, AIM 2 will address the
impact of Ab class on ADCP by BM cells, and AIM 3 will address the impact of BM maturation over time on
ADCP activity. These data will allow the field to better understand the potential contribution of ADCP mediated
by BM cells to the reduction of MTCT of HIV, and may well be applicable to other pathogens that threaten
infants over the course of lactation.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca Powell其他文献
Rebecca Powell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca Powell', 18)}}的其他基金
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
- 批准号:
10470802 - 财政年份:2020
- 资助金额:
$ 21.19万 - 项目类别:
Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size
人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响
- 批准号:
10222911 - 财政年份:2020
- 资助金额:
$ 21.19万 - 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
- 批准号:
10177618 - 财政年份:2020
- 资助金额:
$ 21.19万 - 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
- 批准号:
10240336 - 财政年份:2020
- 资助金额:
$ 21.19万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Fellowship Programs














{{item.name}}会员




